Dementia treatment: The need for a paradigm shift

Richard I Lindley^{1

2}, Louise Waite³, John Cullen³

Affiliations

¹ Sydney Dementia Network, University of Sydney, Sydney, New South Wales, Australia.
² George Institute for Global Health, Sydney, New South Wales, Australia.
³ Sydney Dementia Network, Concord Hospital and University of Sydney, Concord Hospital (C22), University of Sydney, Sydney, New South Wales, Australia.

Editorial

Richard I Lindley et al. Australas J Ageing. 2019 Sep.

. 2019 Sep;38(3):149-150.

doi: 10.1111/ajag.12698. Epub 2019 Jul 9.

Richard I Lindley^{1

2}, Louise Waite³, John Cullen³

¹ Sydney Dementia Network, University of Sydney, Sydney, New South Wales, Australia.
² George Institute for Global Health, Sydney, New South Wales, Australia.
³ Sydney Dementia Network, Concord Hospital and University of Sydney, Concord Hospital (C22), University of Sydney, Sydney, New South Wales, Australia.

No abstract available

Keywords: cognitive ageing; dementia; geriatrics; neuropathology; randomised controlled trial.

References

1. Livingston G, Sommerlad A, Orgeta V, et al. Dementia prevention, intervention, and care. Lancet. 2017; 390: 2673-2734.
1. Wallace L, Theou O, Godin J, Andrew MK, Bennett DA, Rockwood K. Investigation of frailty as a moderator of the relationship between neuropathology and dementia in Alzheimer's disease: a cross-sectional analysis of data from the Rush Memory and Aging Project. The Lancet Neurology. 2019; 18(2): 177-184.
1. Nelson PT, Dickson DW, Trojanowski JQ, et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain 2019; 142(6): 1503-1527.
1. Boyle PA, Yu L, Wilson RS, Leurgans S, Schneider JA, Bennett DA. Person-specific contribution of neuropathologies to cognitive loss in old age. Ann Neurol 2018; 83: 74-83.